Myriad Genetics · 2 days ago
Computational Scientist II - Scientific Affairs
United States
Full-time
Remote
Entry, Mid Level
$133K/yr - $166K/yr
2+ years expMyriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being. As a Computational Scientist in Scientific Affairs, you will work at the interface of product development and evidence generation to enhance the performance and clinical adoption of Myriad’s products using your computational biology expertise.
BiotechnologyPharmaceuticalPrecision Medicine
Responsibilities
Analyze data from research and biopharma studies, present results to internal stakeholders and to external partners, and ensure successful completion of the studies
Develop custom analysis algorithms and pipelines with good testing and documentation practices
Distill learnings from research and clinical data to identify areas of improvement in our assays, and as appropriate, actively implement those improvements
Author and review scientific manuscripts, abstracts, and conference presentations to communicate key findings and innovations from Myriad’s research efforts
Use technical expertise to stay current with advancements in genomics, bioinformatics, and oncology, ensuring Myriad remains at the forefront of diagnostic innovation
Qualification
Required
PhD with 2+ years of industry experience in applying genomic technologies for clinical applications or product development
Proficient computational skills in Python and use of software-engineering best practices; familiarity with R for statistical analysis and data visualization is a plus
Demonstrated experience developing analysis methods, algorithms, and pipelines, particularly with next generation sequencing (NGS) data
Demonstrated critical scientific thought, independent problem solving and excellent technical communication skills
Working knowledge of nucleic acid chemistry and genetics
Preferred
Preferred experience in R&D with non-invasive technologies, oncology, and regulated clinical diagnostic products (CLIA, FDA)
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
1001-5000 employees
H1B Sponsorship
Myriad Genetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (9)
2023 (4)
2022 (7)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Leadership Team
Sam Raha
CEO | President | Board member
Ben Wheeler
Chief Financial Officer
Recent News
2025-12-24
Company data provided by crunchbase